Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state

International Immunology

Volumn 23, Issue 9, 2011, Pages 537-544

  Broering, Ruth ^a   Montag, Mario ^a   Jiang, Min ^a   Lu, Mengji ^a   Sowa, Jan Peter ^a   Kleinehr, Kathrin ^a   Gerken, Guido ^a   Schlaak, Joerg F ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Autoimmune disease; Dexamethasone; Kupffer cells; Liver sinusoidal endothelial cells; Toll like receptors

Indexed keywords

BETA INTERFERON; CYTOKINE; DEXAMETHASONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; NUCLEAR FACTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CELL ISOLATION; CELL TYPE; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; KUPFFER CELL; LIVER CELL; LIVER DISEASE; LIVER SINUSOID; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEROID THERAPY; UPREGULATION;

EID: 80051880046     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxr048     Document Type: Article

References (47)

1. Boumpas, D. T., Chrousos, G. P., Wilder, R. L., Cupps, T. R. and Balow, J. E. 1993. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann. Intern. Med. 119:1198.
2. Rozkova, D., Horvath, R., Bartunkova, J. and Spisek, R. 2006. Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors. Clin. Immunol. 120:260.
3. Tandon, R., Verma, K., Chawla, B. et al. 2009. Intravenous dexamethasone vs methylprednisolone pulse therapy in the treatment of acute endothelial graft rejection. Eye 23:635.
4. Beuers, U., Wiedmann, K. H., Kleber, G. and Fleig, W. E. 1997. [Therapy of autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis. Consensus of the German Society of Digestive System and Metabolic Diseases]. Z. Gastroenterol. 35:1041.
5. Sandor, F. and Buc, M. 2005. Toll-like receptors. I. Structure, function and their ligands. Folia Biol. (Praha) 51:148.
6. Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J. and Marshak-Rothstein, A. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Tolllike receptors. Nature 416:603.
7. Viglianti, G. A., Lau, C. M., Hanley, T. M., Miko, B. A., Shlomchik, M. J. and Marshak-Rothstein, A. 2003. Activation of autoreactive B cells by CpG dsDNA. Immunity 19:837.
8. Pasare, C. and Medzhitov, R. 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299:1033.
9. Kouskoff, V., Lacaud, G. and Nemazee, D. 2000. T cellindependent rescue of B lymphocytes from peripheral immune tolerance. Science 287:2501.
10. Knolle, P. A. and Gerken, G. 2000. Local control of the immune response in the liver. Immunol. Rev. 174:21.
11. Wu, J., Lu, M., Meng, Z. et al. 2007. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology 46:1769.
12. Wu, J., Meng, Z., Jiang, M. et al. 2009. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology 49:1132.
13. Hilkens, C. M., Schlaak, J. F. and Kerr, I. M. 2003. Differential responses to IFN-alpha subtypes in human T cells and dendritic cells. J. Immunol. 171:5255.
14. Cannarile, L., Cuzzocrea, S., Santucci, L. et al. 2009. Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitis. Gastroenterology 136:530.
15. Bhattacharyya, S., Brown, D. E., Brewer, J. A., Vogt, S. K. and Muglia, L. J. 2007. Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood 109:4313.
16. Bhattacharyya, S., Ratajczak, C. K., Vogt, S. K. et al. 2010. TAK1 targeting by glucocorticoids determines JNK and IkappaB regulation in Toll-like receptor-stimulated macrophages. Blood 115:1921.
17. Stienstra, R., Saudale, F., Duval, C. et al. 2010. Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity. Hepatology 51:511.
18. Broering, R., Wu, J., Meng, Z. et al. 2008. Toll-like receptorstimulated non-parenchymal liver cells can regulate hepatitis C virus replication. J. Hepatol. 48:914.
19. Wu, J., Meng, Z., Jiang, M. et al. 2010. Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific. Immunology 129:363.
20. Wang, B., Trippler, M., Pei, R. et al. 2009. Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication. J. Hepatol. 51:1037.
21. Zhang, X., Meng, Z., Qiu, S. et al. 2009. Lipopolysaccharideinduced innate immune responses in primary hepatocytes downregulates woodchuck hepatitis virus replication via interferon-independent pathways. Cell Microbiol. 11:1624.
22. Mao, T. K., Lian, Z. X., Selmi, C. et al. 2005. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology 42:802.
23. Karrar, A., Broome, U., Sodergren, T. et al. 2007. Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis. Gastroenterology 132:1504.
24. Lang, K. S., Georgiev, P., Recher, M. et al. 2006. Immunoprivileged status of the liver is controlled by Toll-like receptor signaling. J. Clin. Invest. 116:2456.
25. Takii, Y., Nakamura, M., Ito, M. et al. 2005. Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis. Lab. Invest. 85:908.
26. Honda, Y., Yamagiwa, S., Matsuda, Y., Takamura, M., Ichida, T. and Aoyagi, Y. 2007. Altered expression of TLR homolog RP105 on monocytes hypersensitive to LPS in patients with primary biliary cirrhosis. J. Hepatol. 47:404.
27. Wang, A. P., Migita, K., Ito, M. et al. 2005. Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis. J. Autoimmun. 25:85.
28. Kikuchi, K., Lian, Z. X., Yang, G. X. et al. 2005. Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology 128:304.
29. Sacher, T., Knolle, P., Nichterlein, T., Arnold, B., Hammerling, G. J. and Limmer, A. 2002. CpG-ODN-induced inflammation is sufficient to cause T-cell-mediated autoaggression against hepatocytes. Eur. J. Immunol. 32:3628.
30. Goldstein, D. R. 2006. Toll like receptors and acute allograft rejection. Transpl. Immunol. 17:11.
31. Goldstein, D. R., Tesar, B. M., Akira, S. and Lakkis, F. G. 2003. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J. Clin. Invest. 111:1571.
32. Deng, J. F., Geng, L., Qian, Y. G. et al. 2007. The role of toll-like receptors 2 and 4 in acute allograft rejection after liver transplantation. Transplant. Proc. 39:3222.
33. Zhai, Y., Shen, X. D., O'Connell, R. et al. 2004. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J. Immunol. 173:7115.
34. Tsung, A., Klune, J. R., Zhang, X. et al. 2007. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J. Exp. Med. 204:2913.
35. Tsung, A., Sahai, R., Tanaka, H. et al. 2005. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemiareperfusion. J. Exp. Med. 201:1135.
36. Zhai, Y., Shen, X. D., Gao, F. et al. 2008. CXCL10 regulates liver innate immune response against ischemia and reperfusion injury. Hepatology 47:207.
37. Zhai, Y., Qiao, B., Gao, F. et al. 2008. Type I, but not type II, interferon is critical in liver injury induced after ischemia and reperfusion. Hepatology 47:199.
38. Beato, M., Herrlich, P. and Schutz, G. 1995. Steroid hormone receptors: many actors in search of a plot. Cell 83:851.
39. Luisi, B. F., Xu, W. X., Otwinowski, Z., Freedman, L. P., Yamamoto, K. R. and Sigler, P. B. 1991. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352:497.
40. Almawi, W. Y. and Melemedjian, O. K. 2002. Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids. J. Mol. Endocrinol. 28:69.
41. Bourke, E. and Moynagh, P. N. 1999. Antiinflammatory effects of glucocorticoids in brain cells, independent of NF-kappa B. J. Immunol. 163:2113.
42. Takeda, K. and Akira, S. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17:1.
43. Calleja, J. L., Albillos, A., Cacho, G., Iborra, J., Abreu, L. and Escartín, P. 1996. Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies. J. Hepatol. 24:308.
44. Fong, T. L., Valinluck, B., Govindarajan, S., Charboneau, F., Adkins, R. H. and Redeker, A. G. 1994. Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology 107:196.
45. Magrin, S., Craxi, A., Fabiano, C. et al. 1994. Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment. Hepatology 19:273.
46. Boor, P. P., Metselaar, H. J., Mancham, S., Tilanus, H. W., Kusters, J. G. and Kwekkeboom, J. 2006. Prednisolone suppresses the function and promotes apoptosis of plasmacytoid dendritic cells. Am. J. Transplant. 6:2332.
47. Rosen, H. R., Hinrichs, D. J., Gretch, D. R. et al. 1999. Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation. Gastroenterology 117:926.